Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update

Go back to Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update

Achieve Life Sciences (ACHV) Reports Q2 Loss of $1.82/Share

August 8, 2018 4:12 PM EDT

Achieve Life Sciences (NASDAQ: ACHV) reported Q2 EPS of ($1.82), versus ($78.66) reported last year.

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

... More